Bempedoic Acid Pregnancy Surveillance Program
Recruiting
Observational Study
Pregnancy
Hyperlipidemias
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- Esperion Therapeutics, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Bempedoic acid pregnancy surveillance program
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period \[LMP\] to pregnancy outcome
Exclusion Criteria:
Contacts